In the presence of glucose, chylomicrons (10 and 100 g/mL) significantly increase GLP-1 secretion from GLUTag cells, murine duodenal cultures, and human duodenal cultures (Psichas et al., 2017)
In addition, simplified dosing regimens and reduced administration constraints are expected to improve treatment adherence and expand adoption across a broader patient population, strengthening the competitive position of oral therapies within the metabolic disease treatment landscape
A patient taking Wegovy 1.7mg weekly can switch to compounded semaglutide 1.7mg weekly without restarting titration or adjusting dose schedules
The cost can be high, the side effects can be intimidating, and honestly, its not something everyone is ready to dive into at full speed
We ensure clients are successful both on and off the medication, providing a truly tailored experience